G34, another connection between MYCN and a pediatric tumor

Cancer Discovery

Volumn 3, Issue 5, 2013, Pages 484-486

  Huang, Miller ^a   Weiss, William A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CHECKPOINT KINASE 1; ISOCITRATE DEHYDROGENASE 1;

ARTICLE; DISEASE ASSOCIATION; DNA METHYLATION; DNA REPLICATION; GENE EXPRESSION; GLIOBLASTOMA; HISTONE METHYLATION; HUMAN;

BRAIN NEOPLASMS; CHILD; GLIOBLASTOMA; HISTONES; HUMANS; MUTATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTEIN ISOFORMS;

EID: 84877625658     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-13-0126     Document Type: Article

References (9)

1. Schwartzentruber J, Korshunov A, Liu X-Y, Jones DTW, Pfaff E, J acob K, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012; 482: 226-31.
2. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012; 44: 251-3.
3. Maze I, Noh K-M, Allis CD. Histone regulation in the CNS: basic principles of epigenetic plasticity. Neuropsychopharmacology 2013; 38: 3-22.
4. Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones DTW, Konermann C, et al. Hotspot mutations in H3F3A and IDH1 defi ne distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012; 22: 425-37.
5. Venneti S, Garimella MT, Sullivan LM, Martinez D, Huse JT, Heguy A, et al. Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas. Brain Pathol. 2013 Feb 18. [Epub ahead of print].
6. Simard JR, Plant M, Emkey R, Yu V. Development and implementation of a high-throughput AlphaLISA assay for identifying inhibitors of EZH2 methyltransferase. Assay Drug Dev Technol. 2013;11: 152-62.
7. Bjerke L, Mackay A, Nandhabalan M, Burford A, Jury A, Popov S, et al. Histone H3.3 mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov 2013; 3:512-19.
8. Puissant A, Frumm SM, Alexe G, Bassil CF, Qi J, Chanthery YH, et al. Targeting MYCN in Neuroblastoma by BET bromodomain inhibition. Cancer Discov 2013; 3: 308-23.
9. Swartling FJ, Savov V, Persson AI, Chen J, Hackett CS, Northcott PA, et al. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell 2012; 21: 601-13.